Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 45 (1), 126-132
- https://doi.org/10.1161/01.hyp.0000150159.48992.11
Abstract
Angiotensin-converting enzyme (ACE) inhibitors elicit outside-in signaling via ACE in endothelial cells. This involves the CK2-mediated phosphorylation of ACE on Ser1270 and the activation of the c-Jun N-terminal kinase (JNK)/c-Jun pathway, resulting in an enhanced endothelial ACE expression. Because cyclooxygenase-2 (COX-2) expression is reported to be increased in subjects treated with ACE inhibitors, we determined the role of ACE signaling in this phenomenon and the transcription factors involved. In lungs from mice treated with the ACE inhibitor ramipril for 5 days, COX-2 expression was increased. A similar (1.5- to 2-fold) increase in COX-2 protein was detected in primary cultures of human endothelial cells treated with ramiprilat. In an endothelial cell line stably expressing human somatic ACE, ramiprilat increased COX-2 promoter activity, an effect not observed in ACE-deficient cells or cells expressing a nonphosphorylatable ACE mutant (S1270A). The ramiprilat-induced, ACE-dependent increase in COX...Keywords
This publication has 26 references indexed in Scilit:
- Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial CellsCirculation Research, 2004
- Shear-induced Cyclooxygenase-2 via a JNK2/c-Jun-dependent Pathway Regulates Prostaglandin Receptor Expression in Chondrocytic CellsJournal of Biological Chemistry, 2003
- Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generationJournal of Endocrinological Investigation, 2003
- Phorbol Ester Induction of Angiotensin-Converting Enzyme Transcription Is Mediated by Egr-1 and AP-1 in Human Endothelial Cells via ERK1/2 PathwayCirculation Research, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertensionMetabolism, 1999
- ACE inhibitor potentiation of bradykinin‐induced venoconstrictionBritish Journal of Pharmacology, 1997
- Treatmetn of mild to moderate hypertension with or without the converting enzyme inhibitor enalaprilThe American Journal of Medicine, 1987
- Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure ResponseClinical Science, 1981
- Induction of angiotensin I-converting enzyme in rat lung with captopril (SQ 14225)European Journal of Pharmacology, 1980